Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • G. Von Minckwitz - (Author)
  • M. Procter - (Author)
  • E. De Azambuja - (Author)
  • D. Zardavas - (Author)
  • M. Benyunes - (Author)
  • G. Viale - (Author)
  • T. Suter - (Author)
  • A. Arahmani - (Author)
  • N. Rouchet - (Author)
  • E. Clark - (Author)
  • A. Knott - (Author)
  • I. Lang - (Author)
  • C. Levy - (Author)
  • D.A. Yardley - (Author)
  • J. Bines - (Author)
  • R.D. Gelber - (Author)
  • M. Piccart - (Author)
  • J. Baselga - (Author)
  • APHINITY Steering Committee And InvestigAtors - (Author)

Details

Original languageEnglish
Pages (from-to)122-131
Number of pages10
JournalNew England Journal of Medicine
Publication statusPublished - 2017
Peer-reviewedYes

External IDs

Scopus 85023170865

Keywords

Sustainable Development Goals